[back] Laetrile
Manuel Navarro, M.D.
[back] Laetrile
Philippines: Dr Manuel Navarro, former Professor of Medicine and Surgery at the University of Santo Tomas, Manila. Associate Member of the National Research Council of the Philippines. A Fellow of the Philippine College of Physicians, the Philippine Society of Endocrinology and Metabolism. A member of the Philippine Medical Association, the Philippine Cancer Society and many other medical groups. Dr Navarro is an internationally recognised cancer researcher with over 100 major scientific papers to his credit, some read before the International Cancer Congress. Dr Navarro has treated terminally ill cancer patients with laetrile for over 25 years. He stated in the Cancer News Journal: "It is my carefully considered clinical judgement, as a practising oncologist and researcher in this field, that I have obtained most significant and encouraging results with the use of laetrile-amygdalin in the treatment of terminal cancer patients... " http://www.credence.org/doctors.html
In the Philippines there is Manuel Navarro, M.D., former Professor of Medicine and Surgery at the University of Santo Tomas in Manila; an Associate Member of the National Research Council of the Philippines; a Fellow of the Philippine College of Physicians, the Philippine Society of Endocrinology and Metabolism; and a member of the Philippine Medical Association, the Philippine Cancer Society, and many other medical groups. He has been recognized internationally as a cancer researcher and has over one-hundred major scientific papers to his credit, some of which have been read before the International Cancer Congress. In 1971 Dr. Navarro wrote:
I ... have specialized in oncology [the study of tumors] for the past eighteen years. For the same number of years I have been using Laetrile—amygdalin in the treatment of my cancer patients. During this eighteen year period I have treated a total of over five hundred patients with Laetrile—amygdalin by various routes of administra-tion, including the oral and the I.V. The majority of my patients receiving Laetrile—amygdalin have been in a terminal state when treatment with this material commenced. It is my carefully considered clinical judgment, as a practicing oncologist and researcher in this field, that I have obtained most significant and encouraging results with the use of Laetrile—amygdalin in the treatment of terminal cancer patients, and that these results are comparable or superior to the results I have obtained with the use of the more toxic standard cytotoxic agents. [World Without Cancer by Edward Griffin]
1. Letter from Dr. Navarro to Mr. Andrew McNaughton, The McNaughton Foundation, dated January 8, 1971, published in the Cancer News Journal, Jan/April, 1971. pp. 19. 20.